We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience, read our Cookie Policy

EP37875
Abstract: In clinical diagnosis, prior to treatment, patients are examined via a series of clinical diagnostic tests. In breast cancer, detection of breast cancer-associated biomarkers is of great significance and human epidermal growth factor receptor 2 (HER2) is particularly important.https://www.creative-biolabs.com/adc/anti-her2-antibody-development.htmSummary: In clinical diagnosis, prior to treatment, patients are examined via a series of clinical diagnostic tests. In breast cancer, detection of breast cancer-associated biomarkers is of great significance and human epidermal growth factor receptor 2 (HER2) is particularly important.https://www.creative-biolabs.com/adc/anti-her2-antibody-development.htm
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Related Posters
Generating antimicrobial peptides using generative adversarial networks.
Khondamir Rustamov
PBPK/RO modeling of anti-PDL1 antibodies
Antonina Nikitich, Oleg Demin Jr
In silico identification and characterization of epitope-based peptide of Buffalo TLR4
Shipra Chauhan, Prashant Kumar, Prashant Singh, Anuradha Bhardwaj, Sanjay Kumar, Navneet Saxena, Dharmendra Kumar, Sajjan Singh, T.K.. Datta, Varij Nayan
Development of QSP model of COVID-19 based on Immune Response Template
Veronika Musatova, Oleg Demin, Maria Kupriyanova, Anna Viktorenko
A brief introduction to non-IgG antibody
Candy Swift